US 8163281
Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis
granted A61KA61K2039/505A61K31/351
Quick answer
US patent 8163281 (Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61K31/351, A61K38/177, A61K45/06